Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal

Bulletin Express

Aug 14

Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.

The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1176343321"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176343321\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176343321?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176343321","market":"us","top_or_hot":-1,"title":"Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal","media":"Bulletin Express","content":"<p>Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.</p>\n<p>The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.</p>\n<p>The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01187","symbol_name":"可孚医疗","start_time":0,"source_url":"","article_id":"1176343321","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176343321","pubTimestamp":1786697265,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01187":"可孚医疗"},"translate_title":"Cofoe Medical Sets 2026 年 8 月 28 日董事会会议批准 2026 年上半年中期业绩和股息提案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01187":1},"content_text":"Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.\nThe board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}